Comparative Pharmacology
Head-to-head clinical analysis: DERMA SMOOTHE FS versus FLUTEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DERMA SMOOTHE FS versus FLUTEX.
DERMA-SMOOTHE/FS vs FLUTEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fluocinolone acetonide is a corticosteroid that binds to glucocorticoid receptors, modulating gene transcription to inhibit pro-inflammatory cytokines and reduce inflammation, vasodilation, and edema.
Flutamide is a nonsteroidal antiandrogen that competitively inhibits the binding of dihydrotestosterone (DHT) to androgen receptors in target tissues, thereby blocking the androgenic effects.
Apply topically as a thin film to affected areas twice daily. Maximum weekly dose should not exceed 60 g.
50 mg orally once daily
None Documented
None Documented
Terminal elimination half-life: 24-36 hours (systemic absorption after topical application); clinical context: prolonged with hepatic impairment.
Terminal elimination half-life: 24–36 hours, permitting once-daily dosing in chronic therapy
Primarily renal (90%) as inactive metabolites; <5% unchanged. Biliary/fecal excretion accounts for <10%.
Renal: ~70% (50% unchanged, 20% as metabolites); Biliary/fecal: ~30%
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid